NEWHALL CHARLES W III sold 19.3% of their position (25K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.27M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/10/2025ACC: 0001628280-25-044797
Director
Since Feb 2026
-25K
Net shares
Net seller
$1.27M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−23.80K
Price / share
$50.73
Trade value
$1.21M
% of position
18.4%
10/9/2025
129.64K→105.84K
Common Stock
Direct
Shares
−1.20K
Price / share
$51.55
Trade value
$61.86K
% of position
1.1%
10/9/2025
105.84K→104.64K
Total
Net shares
−25K
Net value
-$1.27M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/9/2025 | S · Sale | −23.80K | $50.73 | $1.21M | 18.4% | 129.64K | 105.84K |
| Common Stock Direct | 10/9/2025 | S · Sale | −1.20K | $51.55 | $61.86K | 1.1% | 105.84K | 104.64K |
| Total | −25K | -$1.27M | ||||||
Derivative Transactions0
No derivative transactions reported